More often they result from a sequence of small breakdowns across documentation, handling procedures, communication or infrastructure. Understanding the most common issues is therefore essential for companies seeking to strengthen supply chain resilience and protect product integrity.
One of the most frequent challenges in pharmaceutical airfreight involves temperature excursions. Many pharmaceutical products must remain within tightly controlled temperature ranges such as 2–8°C or 15–25°C. Even brief exposure outside these parameters can compromise efficacy or regulatory compliance. While modern packaging solutions offer increasingly robust thermal protection, mishandling during ground operations continues to present risk. Delays on the tarmac, improper placement near aircraft doors or extended transfer times between aircraft and temperature controlled storage facilities can all contribute to excursions.
A recent incident illustrates how seemingly routine circumstances can lead to significant risk exposure. In this case a shipment of temperature controlled oncology medication was transported on a multi-leg route through a major European hub. Due to a miscommunication between the airline and ground handling agent the cargo was offloaded earlier than scheduled and placed in a standard warehouse rather than a dedicated pharmaceutical facility. The error was not detected until several hours later during a routine temperature log review. While the packaging maintained acceptable internal temperatures the manufacturer was forced to conduct a stability assessment before releasing the product for distribution. The event resulted in delays for downstream hospitals and additional quality assurance costs for all parties involved.
Bad paperwork
Documentation errors represent another recurring issue within pharmaceutical airfreight operations. The sector relies heavily on accurate paperwork including air waybills, commercial invoices, import permits and temperature handling instructions. Even minor discrepancies can trigger customs delays or prevent cargo from being loaded onto an aircraft. Because pharmaceutical products often move under strict regulatory oversight a documentation error may result in the cargo being placed on hold until clarification is obtained from the shipper or regulatory authorities.
An anonymised incident from late last year demonstrates the consequences of such mistakes. A shipment of specialised vaccines was scheduled for urgent transport from Asia to a distribution centre in Northern Europe. The export documentation referenced a product classification that differed slightly from the import permit issued by the destination country. Customs officials flagged the discrepancy upon arrival and placed the shipment under administrative review. Although the vaccines remained in temperature controlled storage during the process the delay lasted nearly forty-eight hours. Healthcare providers expecting the delivery had to reschedule vaccination appointments and the logistics provider conducted an internal review to strengthen document verification procedures before cargo acceptance.
Co-ordination vital for success
Operational co-ordination between multiple parties is another area where mishaps frequently occur. Pharmaceutical shipments typically involve shippers, freight forwarders, airlines, ground handlers and customs authorities across several jurisdictions. Each participant must interpret handling instructions consistently and communicate effectively with the next link in the chain. Breakdowns in this co-ordination can create situations where cargo is mishandled or misrouted.
One recent anonymised example involved a high value biologic therapy moving between North America and the Middle East. The shipment required active temperature controlled containers powered by rechargeable batteries. During a scheduled transit stop the ground handling team believed the containers would remain connected to the aircraft power supply until departure. In reality the containers were scheduled for a brief warehouse transfer for security screening. Because the battery status had not been checked during handover the containers remained unpowered for longer than expected. Monitoring data later indicated that the internal temperature approached the upper threshold of the permitted range. Although the product ultimately remained within stability limits the manufacturer required an extensive investigation before releasing the shipment for patient use.
Infrastructure limitations also contribute to pharmaceutical airfreight incidents. Not all airports possess dedicated temperature controlled facilities capable of handling large volumes of pharmaceutical cargo. In emerging markets or smaller transit points the available infrastructure may consist of limited refrigerated space or mobile cooling units. When shipment volumes increase suddenly during vaccine campaigns or seasonal pharmaceutical demand surges these facilities can become congested. Congestion increases the likelihood of cargo waiting in uncontrolled environments or being handled in ways that deviate from standard procedures.
Human factors
Human factors remain a significant contributor as well. Even with automated monitoring systems and digital tracking platforms the industry still depends on trained personnel to interpret instructions, verify documentation and execute handling procedures correctly. Staff turnover, inconsistent training programmes or simple fatigue during peak cargo periods can all lead to errors. In many cases the root cause analysis of pharmaceutical logistics incidents identifies gaps in training or communication rather than technical failure.
Digitalisation has begun to address some of these challenges by improving transparency and traceability throughout the supply chain. Real time temperature monitoring devices allow stakeholders to detect potential excursions earlier while electronic documentation systems reduce the likelihood of clerical mistakes. However, technology alone cannot eliminate risk. Successful pharmaceutical airfreight operations require strong governance structures, clear standard operating procedures and a culture of quality that extends across every organisation involved in the transport process.
Another emerging issue relates to contingency planning. Pharmaceutical shipments often follow complex routes involving several flights and transfer points. When disruptions such as weather delays, airport congestion or geopolitical events occur the cargo may require rapid rerouting. Without carefully prepared contingency protocols there is a risk that alternative routes will not provide the same level of temperature control or regulatory compliance. Logistics providers increasingly emphasise scenario planning to ensure that rerouting decisions preserve the integrity of sensitive healthcare products.
A delicate balance
Ultimately the mishaps seen in pharmaceutical airfreight highlight the delicate balance between speed and control. Air transport offers unmatched delivery times for critical medicines yet the operational environment is inherently dynamic. Aircraft schedules change, airports experience unexpected congestion and regulatory requirements evolve across jurisdictions. Companies that move pharmaceutical cargo must therefore treat risk management as a continuous process rather than a onetime compliance exercise.
By analysing incidents such as temperature control lapses, documentation discrepancies and coordination failures the industry can refine its procedures and strengthen oversight mechanisms. Each investigation contributes to a broader understanding of where vulnerabilities exist within the supply chain. While no logistics network can ever eliminate risk entirely the consistent application of best practices significantly reduces the probability of mishaps and ensures that lifesaving medicines reach patients safely and efficiently.
The post The best laid plans: how pharma shipments can go wrong appeared first on Air Cargo Week.
Go to Source
Author: Anastasiya Simsek
